Alimera Sciences, Inc. (ALIM) Starts Presentation at LD Micro Main Event
Alimera Sciences, Inc. (NASDAQ: ALIM) founded in June 2003, is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. Alimera's commitment to retina specialists and their patients is manifest in Alimera's product portfolio. For more information, visit the company's website at www.alimerasciences.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of…







